Rodrigo Sánchez-Bayona, Medical Oncologist at 12 de Octubre University Hospital, shared a post on LinkedIn:
“Thanks to the Spanish Group of Cancer Patients (GEPAC) for this recognition in the XIV Edition of the GEPAC Awards.
The PROCURE Project, a Spanish multicenter study on genomic variants and toxicity by trastuzumab-deruxtecan, was a finalist in the category of Cancer Research. Thank you to all the patients and researchers who make it possible! More research for more life.”
Other articles featuring Rodrigo Sánchez-Bayona on OncoDaily.